{
  "title": "Controlled Substances Act, 2023",
  "year": "2023",
  "date": "2023-04-18",
  "language": "en",
  "content": "Controlled Substances [No. 2 of 2023 5\nTHE CONTROLLED SUBSTANCES ACT, 2023\nARRANGEMENT OF SECTIONS\nPART I\nPRELIMINARY PROVISIONS\nSection\n1. Short title and commencement\n2. Interpretation\nPART II\nADMINISTRATION\n3. Administration of Act\n4. Functions of Authority\nPART III\nLICENSING FOR CONTROLLED SUBSTANCES\n5. Non-application of Part III\n6. Prohibition of manufacturing, importing, exporting, dealing in or advertising\nof controlled substance\n7. Application for licence\n8. Renewal of licence\n9. Suspension or revocation of licence\n10. Amendment of licence\n11. Submission of quarterly returns\n12. Transfer of licence\n13. Notice of cessation of activity by licensee\nPART IV\nMANUFACTURING, SUPPLY, DISTRIBUTION, SELLING, USING, PRESCRIBING AND\nDISPENSING OF CONTROLLED SUBSTANCES\n14. National annual requirements for controlled substances\n15. Prohibition of placing on market, e.t.c., controlled substance used as\nmedicine without pharmaceutical licence\n16. Application for pharmaceutical licence\n17. Authorisation for certain classes of persons\n18. Prescribing or dispensing controlled substances\n19. Withdrawal and restoration of authorisation\n20. Sell or supply without prescription\n21. Sell or supply by partial filling of prescription\n22. Emergency sell or supply of controlled substance\n23. Retail of precursor chemicals\n24. Consignment of controlled substance in transit\n25. Prohibition of diversion of controlled substance within Republic\n26. Use of controlled substances in health research\nSingle copies of this Act may be obtained from the Government Printer,\nP.O. Box 30136, 10101 Lusaka, Price K 92.00 each.\n6 No. 2 of 2023] Controlled Substances\nPART V\nCLASSIFICATION AND EXEMPTION OF CONTROLLED SUBSTANCES\n27. Classification of controlled substances\n28. Exemptions for certain purposes\n29. Non-prescription preparation containing controlled substance\n30. Temporary classification of controlled substances to avoid\nimminent hazards to public safety\n31. Temporary and permanent classification of anabolic steroids\nPART VI\nREPORTS, RECORDS, INVENTORIES AND REGISTERS\n32. Records or inventory of licensed activity\n33. Registers by other person or institution\n34. Preservation of documents\nPART VII\nINSPECTIONS\n35. Power of authorised officer\n36. Powers of arrest\nPART VIII\nOFFENCES AND PENALTIES\n37. Maintaining controlled substances involved premises\n38. Sale of controlled substance to children\n39. Employing, hiring, using, persuading, inducing, enticing or\ncoercing children to distribute drugs\n40. Prohibition of possession of controlled substance\n41. Offence of import, export, manufacture, possession and use\nof prepared opium\n42. General penalty\n43. Offence by principal officer, shareholder or partner of body\ncorporate or unincorporate body\nPART IX\nGENERAL PROVISIONS\n44. Waiver by Authority\n45. Appeals\n46. Disposal of controlled substance\n47. Requirements in respect of cessation of practise\n48. Forfeiture\n49. Guidelines\n50. Power of Minister to amend Schedules\n51. Regulations\n52. Repeal of Act No. 42 of 1967 and savings and transitional\nprovisions\nSCHEDULES\nControlled Substances [No. 2 of 2023 7\nGOVERNMENT OF ZAMBIA\nACT\nNo. 2 of 2023\nDate of Assent: 14th April, 2003\nAn Act to provide for the granting of a licence to deal in,\nmanufacture, import and export a controlled substance;\nregulate the use, dispensing, manufacture, wholesale,\ntransfer, supply, sell, distribution and possession of a\ncontrolled substance for medicinal, scientific and research\npurposes; provide for procedures and criteria for\nclassification of controlled substances; provide for the\nfunctions of the Zambia Medicines and Regulatory\nAuthority relating to controlled substances; repeal and\nreplace the Dangerous Drugs Act, 1967; and provide for\nmatters connected with, or incidental to, the foregoing.\n[18th April, 2023\nENACTED by the Parliament of Zambia. Enactment\n1. This Act may be cited as the Controlled Substances Act, Short title\n2023, and shall come into operation on the date that the Minister and\ncommence-\nmay appoint, by statutory instrument.\nment\n2. In this Act, unless the context otherwise requires— Interpretation\n“administer” has the meaning assigned to the word in the\nMedicines and Allied Substances Act, 2013; Act No. 3 of\n2013\n“adulterant” means a substance found within a controlled\nsubstance that compromises the quality, safety or\neffectiveness of that controlled substance;\n“agent” means a person who acts on behalf, or on the\ndirection, of a licensed entity when carrying out the licensed\nentity’s business;\n8 No. 2 of 2023] Controlled Substances\n“anabolic steroid” includes a hormonal substance, chemical\nor pharmacological substance related to testosterone;\n“animal health facility” has the meaning assigned to the words\nAct No. 45 in the Veterinary and Veterinary Para-Professions Act,\nof 2010 2010;\n“appropriate authority” means a relevant public body, statutory\ncorporation or person having powers or regulatory functions\nunder any other written law;\n“authorised dispenser” means a pharmacist, veterinary\nsurgeon or any other person authorised by the Authority to\ndispense a controlled substance;\n“authorised officer” means a person assigned to carry out\nthe duties of a law enforcement authority for the purposes\nof this Act and includes—\nAct No. 35 (a) an officer appointed under the Narcotic Drugs and\nof 2021 Psychotropic Substances Act, 2021;\nAct No. 3 of (b) an inspector appointed under the Medicines and Allied\n2013 Substances Act, 2013; and\nAct No. 12 of (c) an inspector appointed under the Environmental\n2011 Management Act, 2011;\n“authorised prescriber” has the meaning assigned to the words\nAct No. 3 of in the Medicines and Allied Substances Act, 2013;\n2013\n“authorised seller” means a registered pharmacist in a\npharmacy or veterinary surgeon in an agro veterinary shop\nof a specified class, who is authorised to sell controlled\nsubstances as prescribed and any other person authorised\nby the Authority;\n“Authority” means the Zambia Medicines Regulatory\nAct No. 3 of Authority established under the Medicines and Allied\n2013 Substances Act, 2013;\n“child” has the meaning assigned to the word in the\nCap. 1 Constitution;\n“coca leaves” means the leaves of any plant of the genus of\nthe erythroxylaceae from which cocaine can be extracted,\neither directly or by chemical transformation;\n“Commission on Narcotic Drugs” means the United Nations\nCommission on Narcotic Drugs established by the\nEconomic and Social Council in 1946, to assist the\nEconomic and Social Council in supervising the application\nof the international drug control treaties;\nControlled Substances [No. 3 of 2023 9\n“controlled substance” means a narcotic drug, psychotropic\nsubstance or precursor chemical set out in the First, Second,\nThird, Fourth, Fifth and Sixth Schedules, but does not include\ndistilled spirits, wine, malt beverages or tobacco as defined\nin the Customs and Excise Act; Cap. 322\n“Convention on Psychotropic Substances” means the\nConvention on Psychotropic Substances which entered into\nforce on 16th August 1976, and was acceded to by the\nRepublic on 28th May, 1993;\n“deal” has the meaning assigned to the word in the Medicines\nand Allied Substances Act, 2013 and includes research for Act No. 3 of\nmedicinal and scientific purposes and 2013\n“dealt” shall be construed accordingly;\n“denaturant” means a substance which renders a controlled\nsubstance unfit for consumption without destroying the\nusefulness in other applications;\n“dispense” means to count, measure or decant a controlled\nsubstance from a bulk supply or to prepare, mix, dissolve\nor supply a controlled substance but does not include the\nadministration of medicine;\n“distribute” means the division and movement of controlled\nsubstances from the premises of a manufacturer, or from\nanother central point to an intermediate point, or to an end\nuser, by means of any method of transport;\n“distributor” means a person who distributes a controlled\nsubstance;\n“diversion” means a change of the intended use or destination\nof a controlled substance;\n“drug addict” means a person addicted to a narcotic drug or\npsychotropic substance;\n“Drug Enforcement Commission” means the Drug\nEnforcement Commission established under the\nConstitution; Cap. 1\n“health facility” has the meaning assigned to words in the\nHealth Professions Act, 2009; Act No. 24 of\n2009\n“health practitioner” means a medical doctor, medical\nlicentiate, pharmacist, dental surgeon or other person as\nthe Minister may, on the advice of the Authority, by statutory\ninstrument, designate;\n“health research” has the meaning assigned to the words in\nthe National Health Research Act, 2013; Act No. 2 of\n2013\n10 No. 2 of 2023] Controlled Substances\n“higher education institution” has the meaning assigned to the\nAct No. 4 of word in the Higher Education Act, 2013;\n2013\n“international agreements” means the United Nations Single\nConvention on Narcotic Drugs, 1961, or any other\nagreement relating to, or impacting on, controlled\nsubstances to which the Republic is a party to;\n“legally disqualified” means the absence of legal capacity as\nprovided in section 4 of the Mental Health Act, 2019;\nAct No. 6 of\n2019 “licence” means a licence issued under section 6;\n“licensee” means a person licensed in accordance with this\nAct;\n“manufacture” in relation to a controlled substance, includes\nany process carried out in the course of making that\ncontrolled substance but does not include dissolving or\ndispensing a product in, or diluting or mixing it with, some\nother substance for purposes of administering it;\n“medicine” has the meaning assigned to the word in the\nAct No. 3 of Medicines and Allied Substances Act, 2013;\n2013\n“medical doctor” means a person registered as a medical doctor\nunder the Health Professions Act, 2009;\nAct No. 24 of\n2009 “medicinal purposes” means the use of a controlled substance\nfor the treatment or prevention of a disease or for some\nother definite curative or therapeutic purpose, but excludes\nthe satisfaction or relief of a habit or craving for the\ncontrolled substance;\n“narcotic drug” means a narcotic drug set out in the First, Second,\nThird and Fourth Schedules;\n“National Health Research Authority” means the National\nAct No. 2 of Health Research Authority established under the National\n2013\nHealth Research Act, 2013;\n“pharmacist” means a person registered as a pharmacist under\nAct No. 24 of the Health Professions Act, 2009;\n2009\n“possess” includes to keep or store a controlled substance, or to\nhave a controlled substance in custody or under control or\nsupervision;\n“precursor chemical” has the meaning assigned to the words in\nAct No. 35 of the Narcotic Drugs and Psychotropic Substances Act,\n2021 2021;\nControlled Substances [No. 2 of 2023 11\n“premises” includes any building, dwelling, shop, office or tent\ntogether with the land on which the building, dwelling, shop,\noffice or tent is situated and the adjoining land used in\nconnection with that land, and includes any vehicle,\nconveyance or vessel;\n“preparation” means a solution or mixture in whatever physical\nstate containing a controlled substance;\n“prescription” has the meaning assigned to the word in the\nMedicines and Allied Substances Act, 2013; Act No. 3 of\n2013\n“prepared opium” means opium prepared for smoking, and\nincludes dross and any other residues remaining after opium\nhas been smoked, and opium, for whatever purpose\nprepared, which is capable of being smoked;\n“psychoactive substance” means a narcotic drug or psychotropic\nsubstance that has potential to affect how the brain\nfunctions and causes changes in mood, awareness, thoughts,\nfeelings, or behaviour;\n“psychotropic substance” has the meaning assigned to the words\nin the Narcotic Drugs and Psychotropic Substances Act, Act No. 35\n2021 and includes the psychotropic substances set out in of 2021\nthe First, Second, Third and Fourth Schedule;\n“register” means a register of controlled substances provided\nfor under section 32;\n“repealed Act” means the repealed Dangerous Drugs Act; Cap. 35\n“sell” has the meaning assigned to the word in the Medicines Act No. 3 of\nand Allied Substances Act, 2013; 2013\n“Single Convention” means the Single Convention on Narcotic\nDrugs which entered into force on 8th August, 1975, and\nwas ratified by the Republic on 13th May, 1998;\n“special stocks” means an amount of controlled substances held\nby the Government for purposes determined by the\nGovernment;\n“stocks”means the amount of controlled substances held in the\nRepublic for medicinal, scientific and research purposes,\nmanufacture or export;\n“temporary classification” means a temporary removal of a\ncontrolled substance from or an addition to the First, Second,\nThird or Fourth Schedule;\n“veterinary surgeon” means a person registered as a veterinary\nsurgeon under the Veterinary and Veterinary Para- Act No. 45\nProfessions Act, 2010; of 2010\n12 No. 2 of 2023] Controlled Substances\n“Zambia Environmental Management Agency” means the\nZambia Environmental Management Agency established\nAct No. 12 under the Environmental Management Act, 2011; and\nof 2011\n“Zambia Revenue Authority” means the Zambia Revenue\nAuthority established under the Zambia Revenue Authority\nAct.\nPART II\nADMINISTRATION\nAdministration 3. (1) The Act shall be administered by the Authority.\nof Act\n(2) The seal of the Authority kept in terms of the Medicines\nAct No. 3 of\n2013 and Allied Substances Act, 2013, shall be used for the purposes of\nthis Act and the impression made for that purpose shall be judicially\nnoticed.\nFunctions of 4. (1) The Authority shall, in addition to the functions under\nAuthority the Medicines and Allied Substances Act, 2013, perform the\nAct No. 3 of\nfunctions conferred on the Authority under this Act.\n2013\n(2) The functions of the Authority are to —\n(a) monitor, supervise and control special stocks and stocks,\nin collaboration with the Drug Enforcement Commission\nand other appropriate authorities, to ensure compliance\nwith this Act and any other written law;\n(b) regulate and control the manufacture, importation,\nexportation, distribution and sale of a controlled\nsubstance;\n(c) issue a licence to deal in, import, export, store, manufacture\nand use, a controlled substance;\n(d) collaborate with national, regional and international\norganisations on matters relating to controlled\nsubstances;\n(e) co-ordinate the assessment on a psychoactive substance\nwith an appropriate authority and recommend to the\nMinister possible control measures under international\nagreements; and\n(f)advise the Minister on a matter relating to a controlled\nsubstance.\nPART III\nLICENSING FOR CONTROLLED SUBSTANCES\nNon- 5. (1) This part shall not apply to a controlled substance that\napplication is listed under the Sixth Schedule.\nof Part III\nControlled Substances [No. 2 of 2023 13\n(2) A person who intends to manufacture, import,export, deal\nin or advertise a controlled substance set out under the Sixth\nSchedule shall apply for a licence to manufacture, import, export,\ndeal in or advertise the controlled substance in accordance with\nthe Environmental Management Act, 2011. Act No. 12\nof 2011\n(3) Despite subsection (2), a person who intends to import a\ncontrolled substance set out in the Sixth Schedule shall, in addition\nto the licence under subsection (2), apply to the Authority for\nauthorisation to import the controlled substance in the prescribed\nmanner and form.\n(4) The Authority shall, within thirty days of receipt of an\napplication under subsection (3), approve or reject the application.\n(5) The Authority shall, where the Authority\n(a) approves an application under subsection (4), notify the\napplicant, in writing; or\n(b) rejects an application under subsection (4), notify the\napplicant, in writing, stating the reasons for the rejection.\n6. (1) A person shall not manufacture, import, export, deal in\nProhibition\nor advertise a controlled substance without a licence issued by the of\nmanufacturing,\nAuthority.\nimporting,\n(2) A person who contravenes subsection (1) commits an exporting,\ndealing in or\noffence and is liable, on conviction, to imprisonment for a term not\nadvertising\nexceeding twenty-five years but the term of imprisonment shall\nof\nnot be less than two years. controlled\nsubstance\n7. (1) A person who intends to manufacture, import, export, Application\ndeal in or advertise a controlled substance set out in the Schedules for licence\nshall apply to the Authority for a licence in a prescribed manner\nand form, on payment of a prescribed fee.\n(2) The Authority shall, within ninety days of receipt of an\napplication under subsection (1), approve or reject the application.\n(3) Despite subsection (2), the Authority shall approve or reject\nan application to import or export a controlled substance within\nfourteen days of the date of receipt of the application.\n(4) The Authority shall, where the Authority rejects an\napplication, inform the applicant of the Authority’s decision in a\nprescribed manner and form stating the reasons for the rejection.\n(5) The Authority shall, where the applicant meets the\nprescribed requirements issue the applicant with an applicable licence\nin a prescribed manner and form.\n14 No. 2 of 2023] Controlled Substances\n(6) A licence granted under subsection (5) shall be valid for—\n(a) one year, for an import and export licence;\n(b) two years, for a manufacturing licence;\n(c) the duration of the advert for a controlled substance for\nan advertising licence; and\n(d) a period as stated on the licence for other licences dealing\nin controlled substances.\nRenewal of 8. (1) A licensee who intends to renew a licence shall, within\nlicence ninety days before the expiration of the licence, apply to the\nAuthority for renewal of the licence in a prescribed manner and\nform, on payment of a prescribed fee.\n(2) The Authority shall, within fourteen days of receipt of an\napplication under subsection (1), approve or reject the application.\n(3) The Authority shall, where the Authority rejects an\napplication, inform the applicant of the Authority’s decision in a\nprescribed manner and form stating the reasons for the rejection.\n(4) The Authority shall, where the applicant meets the\nprescribed requirements, renew the licence.\n(5) The licensee shall, where a licensee does not intend to\nrenew the licence, within ninety days before the expiry of the licence,\nsubmit to the Authority a status report relating to the licensed activity\nin a prescribed manner and form.\n(6) Despite subsection (1), a licence to import or export a\ncontrolled substance, is not renewable.\nSuspension 9. (1) The Authority shall suspend or revoke a licence where\nor revocation the licensee—\nof licence\n(a) obtained the licence by fraud, misrepresentation or\nconcealment of a material fact;\n(b) is legally disqualified to undertake the activity for which\nthe licence was issued;\n(c) fails to take corrective measures following the suspension\nof the licence;\n(d) changes business premises without authorisation; or\n(e) is convicted of an offence under the Act or any other\nwritten law and sentenced to a term of imprisonment\nexceeding six months without the option of a fine.\n(2) The Authority shall, before suspending or revoking a licence,\nnotify the licensee in a prescribed manner and form of the\nAuthority’s intention to suspend or revoke the licence and —\n(a) give reasons for the intended suspension or revocation;\nand\nControlled Substances [No. 2 of 2023 15\n(b) require the licensee to show cause, within a period as\nthe Authority may determine, why the licence should\nnot be suspended or revoked.\n(3) The Authority shall not suspend or revoke a licence under\nthis section if the licensee takes remedial measures to the\nsatisfaction of the Authority within the period specified under\nsubsection (2).\n(4) The Authority may suspend or revoke a licence if the\nlicensee, after being notified under subsection (2), fails to show\ncause or does not take any remedial measures to the satisfaction\nof the Authority.\n(5) The Authority shall, where a licence is revoked under\nthis Act, inform the licensee, in writing, of the revocation of the\nlicence and the licensee shall surrender that licence to the\nAuthority.\n10. (1) A licensee who intends to amend a licence shall apply Amendment\nto the Authority for an amendment of that licence in a prescribed of licence\nmanner and form, on payment of a prescribed fee.\n(2) The Authority shall within fourteen days of receipt of an\napplication under subsection (1)—\n(a) approve or reject the amendment; and\n(b) notify the licensee of the approval of the amendment or\nrejection thereof.\n11. (1) A licensee shall submit to the Authority a quarterly Submission\nreturn on a controlled substance in a prescribed manner and form. of quarterly\nreturns\n(2) A quarterly return referred to under subsection (1) shall\nbe submitted not later than fourteen days of the next quarter.\n(3) A licensee who fails to submit a quarterly return within\nthe prescribed period commits an offence.\n12. (1) A licence issued under this Part shall not be Transfer of\ntransferred to a third party without prior authorisation of the licence\nAuthority.\n(2) A licensee who intends to transfer a licence shall apply\nto the Authority in a prescribed manner and form, on payment of\na prescribed fee.\n(3) The Authority shall, within thirty days of receipt of an\napplication under subsection (2), approve or reject the application.\n(4) The Authority shall, where the Authority rejects the\napplication, inform the applicant in the prescribed manner and\nform stating the reasons for the rejection.\n16 No. 2 of 2023] Controlled Substances\n(5) The Authority shall, where the person to whom a licensee\nintends to transfer the licence meets the prescribed requirements,\ntransfer the licence to that person for the remainder of the validity\nof the licence on terms and conditions that the Authority may\ndetermine.\n(6) Despite subsection (2), an import or export licence is not\ntransferable.\nNotice of 13. (1) A licensee who intends to cease conducting a licensed\ncessation activity under this Act shall notify the Authority in a prescribed\nof activity\nmanner and form.\nby licensee\n(2) A licensee shall, thirty days prior to the cessation of the\nactivity for which the licence was issued, submit to the Authority a\ndetailed report of the licensed activity in a prescribed manner and\nform.\n(3) A licensee shall, where the licensed activity ceases before\nthe expiry of the licence, surrender the licence to the Authority and\nthe Authority shall, on terms and conditions that the Authority may\ndetermine, cancel that licence.\nPART IV\nMANUFACTURING, SUPPLY, DISTRIBUTION, SELLING, USING,\nPRESCRIBING AND DISPENSING OF CONTROLLED SUBSTANCES\nNational 14. The Authority shall determine the total quantity, and\nannual establish national annual requirements, for each class of a controlled\nrequirements\nsubstance in order to provide for—\nfor\ncontrolled (a) requirements for medicinal, scientific and research\nsubstances\npurposes;\n(b) lawful export requirements;\n(c) maintenance of reserve stocks;\n(d) limitation or reduction of individual production quotas to\nthe extent necessary to prevent the aggregate of\nindividual quotas from exceeding the amount prescribed;\n(e) revision of quotas for each class of a controlled substance,\nwhere applicable; and\n(f) determination of the process of fixing the production quota,\ntaking into account—\n(i)the average estimated disposal, inventory and other\nrequirements of the manufacturing sector for\nthe year;\n(ii) the trend of the national disposal rate during the\npreceding year;\nControlled Substances [No. 2 of 2023 17\n(iii) the average production cycle and inventory\nposition of the manufacturing sector;\n(iv) the economic availability of raw materials, yield\nand stability problems;\n(v) national emergencies and disasters; or\n(vi) any other factor that the Authority considers\nnecessary.\n15. A person shall not place on the market, advertise, promote, Prohibition\nmanufacture, sell, import, supply or deal with a controlled substance of placing on\nmarket,\nused as a medicine without a pharmaceutical licence issued by the\ne.t.c.,\nAuthority in accordance with the Medicines and Allied Substances controlled\nAct, 2013. substance\nused as\nmedicine\nwithout\npharmaceutical\nlicence\nAct No. 3 of\n2013\n16. A person who intends to place on the market, advertise, Application\npromote, manufacture, sell, import, supply or deal with a controlled for\npharmaceutical\nsubstance used as a medicine shall apply to the Authority for a\nlicence\npharmaceutical licence in accordance with the Medicines and Allied\nAct No. 3 of\nSubstances Act, 2013, and shall meet the requirements prescribed 2013\nunder this Act.\n17. (1) The following classes of persons are authorised for Authorisation\nthe practice or exercise of that person’s profession, function or for certain\nclasses of\nemployment, to be in possession of, dispose, use, prescribe or\npersons\ndispense, a controlled substance:\n(a) health practitioner;\n(b) veterinary surgeon;\n(c) nurse or midwife specified under section 51 of the Nurses Act No. 10\nand Midwives Act, 2019; of 2019\n(d) a person in charge of a laboratory used for the purpose of\nresearch or education and attached to—\n(i)a higher education institution;\n(ii) a health facility; or\n(iii) any research institution or registered business\nentity; and\n(e) an authorised officer.\n18 No. 2 of 2023] Controlled Substances\n(2) A person referred to under subsection (1) who is in\npossession of a medicine containing a controlled substance, shall,\nexcept when required by the practice of a profession, function or\nemployment, keep the medicine in a locked immovable receptacle\nwhich shall be opened only by that person or another person\nauthorised by virtue of this section, to be in possession of a controlled\nsubstance.\nPrescribing 18. (1) An authorised prescriber may prescribe a controlled\nor substance for treatment in accordance with guidelines issued by\ndispensing the Authority.\ncontrolled\n(2) An authorised dispenser may dispense a controlled\nsubstances\nsubstance for treatment in accordance with guidelines issued by\nthe Authority.\n(3) Guidelines issued under this section shall include matters\nrelating to—\n(a) security of stocks of controlled substances;\n(b) the maintenance of prescribed records on controlled\nsubstances; and\n(c) the quantities of controlled substances which may be\nprovided without supervision for use by an individual in\ntreatment.\nWithdrawal 19. (1) The Authority may, by notice in the Gazette, revoke\nand the authorisation of any person under section 16, where that\nrestoration person—\nof\n(a) commits an offence under this Act, or attempts to solicit,\nauthorisation\nincite, aid or abet, any other person to commit any\noffence under this Act;\n(b) has that person’s licence or certificate of practice\nsuspended or revoked;\n(c) is legally disqualified from, being in possession of, disposing,\nusing, prescribing or dispensing, a controlled substance;\nor\n(d) is proved, to the satisfaction of a medical doctor, to be a\ndrug addict.\n(2) A person whose authorisation is revoked in accordance\nwith subsection (1) may apply to the Authority in a prescribed\nmanner and form, on payment of a prescribed fee for the restoration\nof that person’s authorisation.\n(3) The Authority may, where the authorisation of a person is\nrevoked in accordance with this section, restore the authorisation\nwhere the reasons for revocation cease to exist.\nControlled Substances [No. 2 of 2023 19\n(4) The Authority may, where the Authority revokes the\nauthorisation of a person, seize and take custody of the controlled\nsubstance at the cost of the person whose authorisation has been\nrevoked.\n20. A person shall not sell or supply a controlled substance Sell or supply\nwhich requires a prescription without a prescription. without\nprescription\n21. (1) Despite section 20 and any other written law governing Sell or\ncontrolled substances, a person may sell or supply a controlled supply by\nsubstance for medicinal purposes on partial filling of a prescription partial filling\nof\nfor a controlled substance set out in the First, Second, Third, Fourth\nprescription\nand Fifth Schedules if the—\n(a) partial filling is requested by the patient or the authorised\nprescriber that prescribed the controlled substance; and\n(b) total quantity for the partial filling does not exceed the\ntotal quantity prescribed.\n(2) Except as provided in this section, remaining portions of a\npartially filled prescription for a controlled substance set out in the\nFirst, Second, Third, Fourth and Fifth Schedules may be filled not\nlater than thirty days after the date on which the prescription was\nwritten.\n22. (1) An authorised seller of a controlled substance who is Emergency\nreasonably satisfied that a person requesting a controlled substance sell or\nis an authorised prescriber and by reason of some emergency is supply of\ncontrolled\nunable to furnish a prescription immediately, may, in the absence of\nsubstance\na prescription, sell or supply the controlled substance requested in\naccordance with the directions of the authorised prescriber, except\nthat the authorised prescriber shall undertake to furnish the\nauthorised seller with a prescription, within seven days of the\ndelivery of the controlled substance.\n(2) A person who fails to provide a prescription within the\nperiod specified under subsection (1) commits an offence.\n23. A retailer shall ensure that the sale of a product containing Retail of\nprecursor chemicals set out in the Fifth Schedule is made in precursor\nchemicals\naccordance with the guidelines issued by the Authority.\n24. (1) Where a controlled substance is permitted under the Consignment\nlaw of any foreign country to be exported to another country, and of controlled\nsubstance in\nis transited through the Republic as provided in the Customs and\ntransit\nExcise Act, the exporter shall —\nCap. 322\n(a) notify the Authority, the Drug Enforcement Commission\nand the Zambia Revenue Authority in the prescribed\nmanner and form; and\n20 No. 2 of 2023] Controlled Substances\n(b) not cause, or procure, the controlled substance to be\ndiverted to any destination within the Republic without\nauthorisation.\n(2) A person who contravenes subsection (1) commits an\noffence and is liable, on conviction, to a fine not exceeding five\nhundred thousand penalty units or to imprisonment for a term not\nexceeding five years, or to both.\nProhibition 25. (1) A person shall not without authorisation cause a\nof diversion controlled substance to be diverted within the Republic to a\nof controlled\ndestination other than that which it was originally assigned.\nsubstance\nwithin (2) A person who contravenes subsection (1) commits an\nRepublic offence and is liable, on conviction, to a fine not exceeding five\nhundred thousand penalty units or to imprisonment for a term not\nexceeding five years, or to both.\nUse of 26. (1) A person who intends to carry out health research on\ncontrolled a controlled substance set out in the First, Second, Third, Fourth,\nsubstances\nFifth and Sixth Schedules shall do so in accordance with the\nin health\nresearch National Health Research Act, 2013, and the Medicines and Allied\nAct No. 2 of Substances Act, 2013.\n2013\n(2) The Authority and the National Health Research Authority\nAct No. 3 of\nshall, in setting the criteria for assessing the merits of a research\n2013\nprotocol using a controlled substance, ensure that they are effective\nprocedures to adequately safeguard against diversion of a controlled\nsubstance from legitimate medicinal, scientific or research purposes.\n(3) The Authority and the National Health Research Authority\nshall, in setting the criteria for assessing the merits of a research\nprotocol using a controlled substance under subsection (2), take\ninto account—\n(a) a person’s experience with respect to a controlled\nsubstance;\n(b) previous convictions relating to a controlled substance;\n(c) relevant written laws relating to a controlled substance;\n(d) medical and research experience of the person; and\n(e) any other conduct which may threaten public health and\nsafety.\nControlled Substances [No. 2 of 2023 21\nPART V\nCLASSIFICATION AND EXEMPTION OF CONTROLLED SUBSTANCES\n27. (1) The Minister may, by statutory instrument and on the Classification\nrecommendation of the Authority, and in consultation with of controlled\nsubstances\nappropriate authorities, classify a controlled substance in the First,\nSecond, Third, Fourth, Fifth or Sixth Schedule.\n(2) The Authority shall, in making the recommendation under\nsubsection (1), ensure that the classification is in accordance with\nthe following levels of potential abuse:\n(a) in the case of a controlled substance classified in the First\nSchedule, the controlled substance—\n(i)has a high potential for abuse or poses a serious\nthreat to public health; or\n(ii) is limited or has no use for research, medicinal or\nscientific purposes;\n(b) in the case of a controlled substance classified in the\nSecond Schedule, the controlled substance—\n(i)has major stimulant and addictive properties;\n(ii) has high potential for abuse or poses a serious\nthreat to public health;\n(iii) has an approved medicinal or scientific purpose;\nor\n(iv) may lead to severe psychological or physical\ndependence due to abuse;\n(c) in the case of a controlled substance classified in the Third\nSchedule, the controlled substance includes—\n(i)preparations containing narcotic drugs that are\nintended for legitimate medical use and are\ncompounded in such a way that the preparation\nis unlikely to be abused and that the base\nnarcotic drug cannot be easily extracted; or\n(ii) psychotropic substances which have legitimate\nmedical use, and poses a serious risk to public\nhealth;\n(d) in the case of a controlled substance classified in the Fourth\nSchedule, the controlled substance —\n(i)is rarely used in medical practice and may be\nsubject to special control measures; or\n22 No. 2 of 2023] Controlled Substances\n(ii) includes psychotropic substances which have\nlegitimate use and poses a minor risk to public\nhealth; and\n(e) in the case of a controlled substance classified in the Fifth\nand Sixth Schedule, the controlled substance is a\nprecursor chemical.\nExemptions 28. (1) Subject to section 31, the Authority shall, where the\nfor certain Authority considers that a controlled substance does not have a\npurposes\nsignificant potential for abuse, recommend to the Minister to exempt\nthe controlled substance from the application of any provisions of\nthis Act.\n(2) The Minister may, on the recommendation of the Authority\nand in consultation with an appropriate authority, exempt, by statutory\ninstrument, a controlled substance from the application of any\nprovisions of this Act.\n(3) The Minister may, on the recommendation of the Authority\nand in consultation with an appropriate authority, by statutory\ninstrument, exempt any compound, mixture or preparation containing\na controlled substance from the application of any provisions of\nthis Act if the Authority finds that the compound, mixture or\npreparation contains—\n(a) a controlled substance which is not for administration to a\nhuman being or animal, and which is packaged in a\nform or concentration, or with adulterant or\ndenaturants, and it does not present any significant\npotential for abuse; or\n(b) an anabolic steroid, which is intended for administration\nto a human being or an animal and which, because of its\nconcentration, preparation, formulation or delivery\nsystem, does not present any significant potential for\nabuse.\n(4) The Minister shall, by statutory instrument, revoke the\nexemption of a controlled substance that the Authority finds is being\ndiverted from the purposes specified in subsection (2) or (3).\n(5) The Minister shall, in revoking an exemption of a controlled\nsubstance under this section, consider—\n(a) the scope, duration and significance of the diversion;\n(b) whether the controlled substance is formulated in a manner\nthat it cannot easily be used in the illicit production of\nanother controlled substance;\nControlled Substances [No. 2 of 2023 23\n(c) whether a precursor can be readily recovered from the\ncontrolled substance;\n(d) the evidence of the diversion of the controlled substance;\nand\n(e) any other relevant issue that contravenes this Act and\nany other written law.\n(6) Subject to subsection (8), the Minister shall, on the\nrecommendation of the Authority and in consultation with an\nappropriate authority, on an application by a licensee of a controlled\nsubstance, whose exemption is revoked by statutory instrument,\nreinstate the exemption of that controlled substance, where the\nMinister is satisfied that the controlled substance shall be\nmanufactured, imported, exported and dealt with in a manner that\nprevents diversion.\n(7) The Minister shall, on the recommendation of the Authority,\nin reinstating an exemption of a controlled substance, as specified\nunder subsection (6), consider—\n(a) the package sizes and manner of packaging of the\ncontrolled substance;\n(b) the manner of distribution and advertising of the controlled\nsubstance;\n(c) any action taken by the manufacturer to prevent diversion\nof the controlled substance; and\n(d) other factors that are relevant to, and consistent with,\npublic health and safety, including the factors specified\nin subsection (3).\n(8) A person shall not divert a controlled substance without\nauthorisation from the Authority as prescribed.\n(9) A person who contravenes subsection (8) commits an\noffence and is liable, on conviction, to a penalty specified under the\nNacortic Drugs and Psychotropic Substances Act, 2021. Act No. 35 of\n2021\n29. Subject to the Medicines and Allied Substances Act, 2013, Non-\nthe Minister may, by statutory instrument, exempt a preparation prescription\npreparation\ncontaining a controlled substance from the application of this Act,\ncontaining\nif the preparation containing a controlled substance may be sold\ncontrolled\nover the counter without a prescription. substance\nAct No. 3 of\n2013\n24 No. 2 of 2023] Controlled Substances\nTemporary 30. (1) Despite sections 28 and 29, the Minister may, on the\nclassification recommendation of the Authority, by statutory instrument, order\nof controlled\nsubstances to the temporary classification of a controlled substance to avoid an\navoid imminent hazard to the public.\nimminent\nhazards to (2) The Minister may, on the recommendation of the Authority,\npublic safety by statutory instrument, remove a controlled substance from a\nSchedule on a temporary basis, where reasons advanced for the\ngrant of the temporary classification cease to exist.\nTemporary 31. (1) The Minister may, on the recommendation of the\nand Authority, by statutory instrument, order the temporary classification\npermanent\nof an anabolic steroid as a controlled substance, if the Authority\nclassification\nfinds that the classification shall assist in preventing abuse or misuse\nof anabolic\nsteroids of the anabolic steroid.\n(2) The Minister may, on the recommendation of the Authority,\nby statutory instrument, remove an anabolic steroid from a Schedule\non a temporary basis, where the reasons advanced for the grant of\nthe temporary classification cease to exist.\n(3) The Minister may, on the recommendation of the Authority,\nby statutory instrument, permanently include an anabolic steroid as\na controlled substance in the appropriate Schedule.\nPART VI\nREPORTS, RECORDS, INVENTORIES AND REGISTERS\nRecords or 32. (1) A licensee shall establish and maintain a complete and\ninventory of accurate record or inventory of each controlled substance\nlicensed\nmanufactured, imported, exported, advertised or dealt in.\nactivity\n(2) A health facility or animal health facility shall establish and\nmaintain a complete and accurate record or inventory of each\ncontrolled substance in the health facility or animal health facility’s\npossession, disposed of, used, prescribed or dispensed by a person\nauthorised under section 16.\n(3) In the case of a person in charge of a laboratory used for\nthe purpose of research or education and attached to a higher\neducation institution, research institution or registered business\nentity, that higher education institution, research institution and\nregistered business entity shall establish and maintain a complete\nand accurate record or inventory of each controlled substance.\n(4) The record or inventory referred to in this section shall be\nkept and maintained in a prescribed manner and form.\n(5) A person who contravenes this section commits an offence.\nControlled Substances [No. 2 of 2023 25\n33. (1) The Authority may require a person or institution, other Registers by\nthan a person or institution referred to under section 32, in possession other person\nof a controlled substance for disposal, use, prescribing or dispensing or institution\nto keep and maintain a register of the controlled substances in that\nperson or institution’s possession in a prescribed manner and form.\n(2) A person who contravenes this section commits an offence.\n34. (1) A licensee, a health facility, animal health facility, higher Preservation\neducation institution, research institution, registered business entity of\nor other person or institution so required by the Authority shall documents\npreserve registers, records, inventories, books, prescriptions, orders\nin writing and other documents issued or made for the purposes of\nthis Act for a period of five years from the date on which the last\nentry was made or issued, as prescribed.\n(2) A person who contravenes this section commits an offence.\nPART VII\nINSPECTIONS\n35. (1) An authorised officer may, for the purpose of enforcing Power of\nthe provisions of this Act, with a warrant, at any reasonable time— authorised\nofficer\n(a) enter any premises, pharmacy, agro veterinary shop,\ncontainer, vessel, vehicle, aircraft or other conveyance\nthat the authorised officer has reasonable grounds to\nbelieve is used for the commission of an offence or for\npurposes contrary to the provisions of this Act;\n(b) search any premises where any activity in relation to\ncontrolled substances is being undertaken, including a\npharmacy, an agro veterinary shop, a container, vessel,\nvehicle, an aircraft or other conveyance, or the premises\nof a manufacturer, importer, exporter or dealer of any\ncontrolled substances or any person licensed or regulated\nunder this Act, including a private dwelling, where\ninformation or documents which may be relevant to an\ninspection may be kept or which are being used for the\ncommission of an offence under this Act;\n(c) search any person on the premises if the authorised officer\nhas reasonable grounds to believe that the person has\npossession of an article, document, record or controlled\nsubstance that has a bearing on an investigation, except\nthat a person shall only be searched by a person of the\nsame sex;\n26 No. 2 of 2023] Controlled Substances\n(d) examine any document, record, book, article or controlled\nsubstance found on the premises that has a bearing on\nan inspection or investigation;\n(e) require information to be given about any document,\nrecord, book, article or controlled substance in any\npremises by—\n(i)the owner of the premises;\n(ii) the person in control of the premises;\n(iii) any person who has control of the document,\nrecord, book, article or controlled substance; or\n(iv) any other person who may have the information;\n(f)seize any document, book, record, article, computer or other\nelectronic storage device or controlled substance that\nhas a bearing on an inspection or investigation or is used\nfor purposes contrary to the provisions of this Act;\n(g) take samples of any controlled substance as may be\nnecessary for the purposes of testing, examination or\nanalysis;\n(h) take extracts from, or make copies of, any book, record\nor document found on the premises that has a bearing\non an inspection or investigation; or\n(i)use any computer system or any other electronic device\non the premises, or require the assistance of any person\non the premises to use that computer system or\nelectronic device, to—\n(i)search any data contained in, or available to, the\ncomputer system or electronic device;\n(ii) reproduce any record from the data;\n(iii) seize any output from the computer or electronic\ndevice for examination and copying; and\n(iv) attach and, if necessary, remove from the\npremises for examination and safeguarding any\ndocument, record, book or article that has a\nbearing on an inspection or investigation.\n(2) An authorised officer who removes any document, book,\nrecord or article from any premises under subsection (1) shall—\n(a) issue a receipt for the document, book, record or article\nto the owner of, or person in control of, the premises;\nand\nControlled Substances [No. 2 of 2023 27\n(b) return the document, book, record or article as soon as\npracticable after achieving the purpose for which it\nwas removed.\n(3) A person commits an offence if that person—\n(a) delays, assaults, threatens or obstructs an authorised officer\nin the performance of the authorised officer’s functions;\n(b) refuses to give an authorised officer reasonable assistance\nthat the authorised officer may require for the purpose\nof exercising the authorised officer’s powers;\n(c) gives an authorised officer false or misleading information\nin answer to an inquiry made by the authorised officer;\nor\n(d) impersonates an authorised officer or presents oneself to\nbe an authorised officer.\n(4) A person convicted of an offence under subsection (3) is\nliable, on conviction, to a fine not exceeding two hundred thousand\npenalty units or to imprisonment for a term not exceeding two years,\nor to both.\n(5) An authorised officer shall furnish a written report and\nany other information relating to an inspection to an appropriate\nauthority, as the Authority may require.\n(6) Nothing in this section requires a person to disclose or\nproduce information or a document, if the person would in an action\nin a court be entitled to refuse to disclose or produce the information\nor document.\n36. (1) An authorised officer may arrest a person, without Powers of\nwarrant, where the authorised officer has reasonable grounds to arrest\nbelieve that the person—\n(a) is committing or has committed an offence under this\nAct;\n(b) is about to commit an offence under this Act and there is\nno other way to prevent the commission of the offence;\n(c) shall, unless arrested—\n(i)escape or cause unreasonable delay, trouble or\nexpense in being made answerable to justice;\n(ii) interfere with the witnesses; or\n(iii) tamper with or destroy relevant evidence or\nmaterial; or\n(d) is willfully obstructing the authorised officer in the execution\nof the authorised officer’s duties.\n28 No. 2 of 2023] Controlled Substances\n(2) An authorised officer shall, where the authorised officer\narrests a person under subsection (1), handover the person to a\npolice officer, or surrender that person to a police post or station\nwithin twenty four hours of the arrest.\n(3) An authorised officer who makes an arrest under\nsubsection (1) shall, without undue delay, have the person so arrested\nbrought before a court of competent jurisdiction to be dealt with\naccordingly.\nPART VIII\nOFFENCES AND PENALTIES\nMaintaining 37. (1) Except as authorised by this Act, a person commits an\ncontrolled offence if that person—\nsubstances\n(a) knowingly opens, leases, rents, uses or maintains any place,\ninvolved\npremises whether permanently or temporarily, for the purpose of\nmanufacturing, distributing or using any controlled\nsubstance; or\n(b) manages or controls any place, whether permanently or\ntemporarily, either as an owner, lessee, agent, employee,\noccupant or mortgagee, or knowingly and intentionally\nrents, leases, profits from, or makes available for use,\nwith or without compensation, the place for the purpose\nof unlawfully manufacturing, storing, distributing or using\na controlled substance.\n(2) A person convicted of an offence under subsection (1) is\nliable, on conviction, to imprisonment for a term not exceeding five\nyears.\nSale of 38. (1) Except as provided in this Act, a person who deals in\ncontrolled a controlled substance with a child commits an offence and is liable,\nsubstance to on conviction, to a fine not exceeding two million penalty units or to\nchildren\nimprisonment for a term not exceeding fifteen years, or to both.\n(2) Where the controlled substance referred to under\nsubsection (1) is set out in the Fifth and Sixth Schedules, the person\nreferred to under subsection (1) is liable, on conviction, to a fine\nnot exceeding one million penalty units or imprisonment for a term\nnot exceeding ten years, or to both.\nEmploying, 39. (1) Despite any other written law, a person commits\nhiring, using,\nan offence if that person knowingly—\npersuading,\ninducing, (a) employs, hires, uses, persuades, induces, entices or coerces\nenticing or\ncoercing a child to contravene this Act; or\nchildren to\ndistribute\ndrugs\nControlled Substances [No. 2 of 2023 29\n(b) employs, hires, uses, persuades, induces, entices or coerces\na child to assist in avoiding detection or apprehension\nfor any offence under this Act.\n(2) A person convicted of an offence under subsection (1) is\nliable, on conviction, to a fine not exceeding one million penalty\nunits or to imprisonment for a term not exceeding ten years, or to\nboth.\n40. (1) A person shall not possess a controlled substance\nProhibition\nwithout authorisation under this Act or any other written law. of\npossession\n(2) A person who contravenes subsection (1) commits an\nof controlled\noffence and is liable, on conviction, to imprisonment for a term not\nsubstance\nexceeding fifteen years.\n(3) This section shall not apply to an appropriate authority\nprocuring a controlled substance in accordance with the\nrequirements of any written law.\n41. (1) A person who intends to import, export, manufacture Offence of\nor use prepared opium shall apply for authorisation from the import,\nAuthority. export,\nmanufacture,\n(2) A person commits an offence if that person— possession\n(a) imports into, or exports from the Republic any prepared and use of\nprepared\nopium;\nopium\n(b) manufactures or otherwise deals in prepared opium;\n(c) has in that person’s possession any prepared opium;\n(d) being the occupier of any premises, permits the premises\nto be used for the purpose of the preparation of prepared\nopium for smoking, or the sale or smoking, of prepared\nopium;\n(e) is concerned in the management of any premises used for\npurposes of paragraph (d);\n(f)has in that person’s possession any pipes or other utensils\nfor use in connection with the smoking of prepared\nopium or any utensils used in connection with the\nprepared opium for smoking; or\n(g) smokes, or otherwise uses, prepared opium.\n(2) A person who commits an offence under subsection (1) is\nliable, on conviction, to a fine not exceeding one million penalty\nunits or to imprisonment for a term not exceeding ten years, or to\nboth.\n30 No. 2 of 2023] Controlled Substances\n42. A person who commits an offence under this Act for which\nGeneral\npenalty a specific penalty is not provided for is liable, on conviction, to a\nfine not exceeding three hundred thousand penalty units or to\nimprisonment for a term not exceeding three years, or to both.\nOffences by 43. Where an offence under this Act is committed by a body\nprincipal corporate or unincorporate body, with the knowledge, consent or\nofficer,\nconnivance of the director, manager shareholder or partner, that\nshareholder\ndirector, manager, shareholder or partner of the body corporate or\nor partner of\nbody unincorporate body commits an offence and is liable, on conviction,\ncorporate or to the penalty specified for that offence.\nunincorporate\nbody\nPART IX\nGENERAL PROVISIONS\nWaiver by 44. The Authority may waive certain requirements under this\nAuthority Act for the purposes of an importation or exportation of a controlled\nsubstance where a national or global disaster or health emergency\nis declared.\nAppeals 45. (1) A person who is aggrieved by a decision made\nunder this Act may appeal to the Minister within thirty days of the\ndate of the decision.\n(2) The Minister shall hear and determine an appeal referred\nto under subsection (1) within ninety days from the date of appeal.\n(3) A person aggrieved with the decision of the Minister\nunder subsection (1), may appeal to the High Court.\nDisposal of 46. The Authority shall, in collaboration with the Zambia\ncontrolled Environmental Management Agency and any other appropriate\nsubstance authority, dispose of expired, obsolete or unwanted controlled\nsubstances.\nRequirements 47. (1) A person in lawful possession of a controlled substance\nin respect of shall, before ceasing to practise in a profession or being in\ncessation of\nemployment —\npractise\n(a) where that person is being succeeded by another person\nauthorised —\n(i)physically check with, and hand over to the\nsuccessor all controlled substances;\n(ii) submit to the licensee a signed statement, including\nthe signature of the successor, certifying that\nthe controlled substances have been physically\nchecked and handed over in accordance with\nsubparagraph (i);\nControlled Substances [No. 2 of 2023 31\n(iii) after handing over the controlled substance, rule\noff each page of the register on which an entry\nis made, and both the person and the successor\nshall, when satisfied that it is a true record of\nthe controlled substances on hand, sign each\npage; and\n(iv) if either person is not satisfied that an entry,\nunder subparagraph (iii), is a true record, that\nperson shall refuse to sign the page and shall\nimmediately inform the licensed entity of the\nreason for the refusal; or\n(b) where that person is not succeeded by another authorised\nperson—\n(i)inform the Authority of the arrangements made\nfor the disposal of the controlled substances;\nand\n(ii) immediately after disposing of the controlled\nsubstances, that person shall notify the Authority\nof the disposal of the controlled substances and\nshall, at the same time, forward the register and\nthe supporting prescriptions and written orders\nto the Authority who shall retain them for a\nperiod of five years from the latest date of entry.\n(2) Where the arrangements under subsection (1)(b), are not\nmade or are not to the satisfaction of the Authority, the controlled\nsubstances shall be disposed of in the manner that the Authority\nmay determine, in consultation with the Zambia Environmental\nManagement Agency.\n48. Subject to the Forfeiture of Proceeds of Crime Act, 2010, Forfeiture\na person convicted of an offence under this Act shall forfeit to the Act No. 19 of\n2010\nRepublic all articles in respect of which the offence was committed,\nand the court before which that person is convicted may order\nthose articles to be destroyed or otherwise disposed of as the\ncourt thinks fit at the cost of the convicted person.\n49. (1) The Authority may, in the exercise of the Authority’s Guidelines\nfunctions under this Act, issue guidelines as are necessary for the\nbetter carrying out of the provisions of this Act.\n(2) The Authority shall publish the guidelines issued under this\nAct in the Gazette and any other electronic media that the Authority\nmay determine.\n32 No. 2 of 2023] Controlled Substances\n(3) The guidelines shall take effect on the date of publication\nand shall bind all persons licensed or authorised under this Act.\nPower of 50. (1) The Minister may, by statutory instrument, on the\nMinister to recommendation of the Authority and in consultation with the Drug\namend\nEnforcement Commission and any other appropriate authority,\nSchedules\namend the Schedules where it is found that a controlled substance—\n(a) has a potential for abuse as categorised in section 27; or\n(b) fails to meet the requirements for inclusion in any of the\nSchedules.\n(2) The Minister shall, in amending a Schedule under subsection\n(1), take into consideration the—\n(a) actual or relative potential for abuse;\n(b) scientific evidence of its pharmacological effect, if known;\n(c) state of current scientific knowledge regarding a controlled\nsubstance;\n(d) history and current pattern of abuse;\n(e) scope, duration and significance of abuse;\n(f)potential risk to public health;\n(g) psychic or physiological dependence liability; or\n(h) possibility of the substance being a precursor chemical\nof a substance already controlled as specified in this\nAct.\n(3) The Authority shall, in making the recommendation under\nsubsection (1), consider the decision of the Commission on Narcotic\nDrugs on categorisation of a controlled substance.\nRegulations 51. (1) The Minister may, on the recommendation of the\nAuthority, by statutory instrument, make Regulations for the better\ncarrying out of the provisions of this Act and for anything required\nto be prescribed as specified in this Act.\n(2) Despite the generality of subsection (1), Regulations made\nunder subsection (1) may—\n(a) provide for measures to prevent diversion of controlled\nsubstances;\n(b) provide for the provision of emergency medical services,\na public health emergency or a mass casualty event\nusing controlled substances, consistent with this Act;\n(c) prescribe fees or charges payable in respect of any matter\narising and provided for, or authorised by this Act;\nControlled Substances [No. 2 of 2023 33\n(d) prescribe the forms for applications, licences, approvals,\nregisters, notices, orders and any other documents\nrequired for the purposes of this Act;\n(e) provide for the supply and monitoring of special stocks\nand stocks; and\n(f) prescribe the information to be given in returns and other\ndocuments submitted or made for the purposes of this\nAct.\n52. (1) The Dangerous Drugs Act, 1967 is repealed. Repeal of\n(2) Despite subsection (1)— Act No. 42\nof 1967 and\n(a) a licence issued under the repealed Act shall be considered savings and\nas having been issued under this Act; and transitional\nprovisions\n(b) an application for a licence under the repealed Act shall\nCap. 95\nbe considered and issued in accordance with this Act.\n34 No. 2 of 2023] Controlled Substances\nFIRST SCHEDULE\n(Sections 2, 21, 26 and 27)\nPart A: Narcotic Drugs\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nAcetorphine 3-O-acetyltetrahydro-7á-(1-hydroxy-1-\nmethylbutyl)-6,14-endoethenooripavine (derivative\nof thebaine)\nAcetyl-Alpha-Methylfentanyl N-[1-(á-methylphenethyl)-4- piperidyl]acetanilide\nAcetylfentanyl N-[1-(2-phenylethyl)-4-piperidyl]-N-\nphenylacetamide\nAcetylmethadol 3-acetoxy-6-dimethylamino-4,4-diphenylheptane\nAcryloylfentanyl (Acrylfentanyl) N-phenyl-N-[1(2-phenylethyl) piperidin-4-yl]prop-2-\nenamide\nAlfentanil N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-\nyl)ethyl]-4(methoxymethyl)-4-piperidinyl]-N-\nphenylpropanamide\nAH-7921 3,4-dichloro-N-[(1-\ndimethylamino)cyclohexylmethyl]benzamide\nAllylprodine 3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine\nAlphacetylmethadol α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane\nAlphameprodine α-3-ethyl-1-methyl-4-phenyl-4-\npropionoxypiperidine\nAlphamethadol α-6-dimethylamino-4,4-diphenyl-3-heptanol\nAlpha-Methylfentanyl N-[1-(á-methylphenethyl)-4-piperidyl]\npropionanilide\nAlpha-Methylthiofentanyl N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]\npropionanilide\nAlphaprodine α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine\nAnileridine 1-p-aminophenethyl-4-phenylpiperidine-4-\ncarboxylic acid ethyl ester\nBenzethidine 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-\ncarboxylic acid ethyl ester\nBenzylmorphine 3-benzylmorphine\nBetacetylmethadol ß-3-acetoxy-6-dimethylamino-4,4-diphenylheptane\nBeta-Hydroxyfentanyl N-[1-(â-hydroxyphenethyl)-4-piperidyl]\npropionanilide\nBeta-Hydroxy-3- N-[1-(â-hydroxyphenethyl)-3-methyl-4-piperidyl]\nMethylfentanyl propionanilide\nBetameprodine ß-3-ethyl-1-methyl-4-phenyl-4-\npropionoxypiperidine\nBetamethadol ß-6-dimethylamino-4,4-diphenyl-3-heptanol\nBetaprodine ß-1,3-dimethyl-4-phenyl-4-propionoxypiperidine\nBezitramide 1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-\npropionyl-1benzimidazolinyl)piperidine\nâ-3\nControlled Substances [No. 2 of 2023 35\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nButyrfentanyl N-phenyl-N-[1-(2-phenylethyl)-4-\npiperidinyl] butanamide\nCannabis 1\nCannabis Resin, Extracts and\nTinctures _\nCarfentanil Methyl 1-(2-phenylethyl)-4-[phenyl (propanoyl)\namino] piperidine-4-carboxylate\nClonitazene 2-(p-chlorobenzyl)-1-diethylaminoethyl-5-\nnitrobenzimidazole\nCoca Leaf 2 _\nCocaine methyl ester of benzoylecgonine (an alkaloid found in\ncoca leaves or prepared by synthesis from ecgonine)\nCodoxime dihydrocodeinone-6-carboxymethyloxime (derivate of\nmorphine)\nDesomorphine Dihydrodesoxymorphine (derivative of morphine)\nDextromoramide (+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-\npyrrolidinyl)butyl]morpholine (dextro-rotatory isomer\nof moramide)\nDiampromide N-[2-(methylphenethylamino)-propyl] propionanilide\nDiethylthiambutene 3-diethylamino-1,1-di-(2’-thienyl)-1-butene\nDifenoxin 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic\nacid\nDihydroetorphine 7,8-dihydro-7á-[1-(R)-hydroxy-1-methylbutyl]-6,14-\nendoethanotetrahydrooripavine (derivative of\netorphine)\nDihydromorphine (derivative of morphine)\nDimenoxadol 2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate\nDimepheptanol 6-dimethylamino-4,4-diphenyl-3-heptanol\nDimethylthiambutene 3-dimethylamino-1,1-di-(2’-thienyl)-1-butene\nDioxaphetyl Butyrate ethyl-4-morpholino-2,2-diphenylbutyrate\nDiphenoxylate 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-\n4-carboxylic acid ethyl ester\nDipipanone 4,4-diphenyl-6-piperidine-3-heptanone\nDrotebanol 3,4-dimethoxy-17-methylmorphinan-6â,14-diol\nEcgonine (1R,2R,3S,5S)-3-hydroxy-8-methyl-8-\nazabicyclo [3.2.1]octane-2-carboxylic acid\nEthylmethylthiambutene 3-ethylmethylamino-1,1-di-(2’-thienyl)-1-butene\nEtonitazene 1-diethylaminoethyl-2-p-ethoxybenzyl-5-\nnitrobenzimidazole\n1 the flowering or fruiting tops of the cannabis plant (resin not extracted) the separated resin,\ncrude or purified, obtained from the cannabis plant\n2 the leaf of the coca bush (plant material), except a leaf from which all ecgonine, cocaine and\nany other ecgonine alkaloids have been removed\n36 No. 2 of 2023] Controlled Substances\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nEtorphine tetrahydro-7á-(1-hydroxy-1-methylbutyl)-6,14-\nendo-ethenooripavine (derivative of the baine)\nEtoxeridine 1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-\n4-carboxylic acid ethyl ester\nFentanyl 1-phenethyl-4-N-propionylanilinopiperidine\n4-Fluoroisobutyrfentanyl N-(4-fluorophenyl)-N-(1-phenetylpiperidin-4-\n(4-FIBF, pFIBF) yl)isobutyramide\nFuranylfentanyl N-phenyl-N-[1-(2-phenylethyl)piperidin-4-\nyl]furan-2-carboxamide\nFurethidine 1-(2-tetrahydrofurfuryloxyethyl)-4-\nphenylpiperidine-4-carboxylic acid ethyl ester\nHeroin diacetylmorphine (derivative of morphine)\nHydrocodone dihydrocodeinone (derivative of morphine)\nHydromorphinol 14-hydroxydihydromorphine (derivative of\nmorphine)\nHydromorphone dihydromorphinone (derivative of morphine)\nHydroxypethidine 4-m-hydroxyphenyl-1-methylpiperidine-4-\ncarboxylic acid ethyl ester\nIsomethadone 6-dimethylamino-5-methyl-4,4-diphenyl-3-\nhexanone\nKetobemidone 4-m-hydroxyphenyl-1-methyl-4-\npropionylpiperidine\nLevomethorphan (-)-3-methoxy-N-methylmorphinan\nLevomoramide (-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-\npyrrolidinyl)butyl]morpholine\nLevophenacylmorphan (-)-3-hydroxy-N-phenacylmorphinan\nLevorphanol2 (-)-3-hydroxy-N-methylmorphinan\nMetazocine 2-hydroxy-2,5,9-trimethyl-6,7-benzomorphan\nMethadone 6-dimethylamino-4,4-diphenyl-3-heptanone\nMethadone Intermediate 4-cyano-2-dimethylamino-4,4-diphenylbutane\nMethyldesorphine 6-methyl-6-deoxymorphine (derivative of\nmorphine)\nMethyldihydromorphine 6-methyldihydromorphine (derivative of morphine)\n3-Methylfentanyl N-(3-methyl-1-phenethyl-4-piperidyl)\npropionanilide\n3-Methylthiofentanyl N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]\npropionanilide\nMetopon 5-methyldihydromorphinone (derivative of\nmorphine)\nMoramide Intermediate 2-methyl-3-morpholino-1,1-diphenylpropane\ncarboxylic acid\nControlled Substances [No. 2 of 2023 37\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nMorpheridine 1-(2-morpholinoethyl)-4-phenylpiperidine-4-\ncarboxylic acid ethyl ester\nMorphine the principal alkaloid of opium and of opium\npoppy\nMorphine Methobromide3 (5α, 6α)-3,6-Dihydroxy-17,17-dimethy l-7, 8didehydro-\n4,5-epoxymorphinan-17-ium bromide\nMorphine-N-Oxide (derivate of morphine)\nMPPP 1-methyl-4-phenyl-4-piperidinol propionate (ester)\nMT-45 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine\nMyrophine Myristylbenzylmorphine (derivate of morphine)\nNicomorphine 3,6-dinicotinylmorphine (derivate of morphine)\nNoracymethadol ()-α-3-acetoxy-6-methylamino-4,4-diphenylheptane\nNorlevorphanol (-)-3-hydroxymorphinan\nNormethadone 6-dimethylamino-4,4-diphenyl-3-hexanone\nNormorphine demethylmorphine (derivate of morphine)\nNorpipanone 4,4-diphenyl-6-piperidino-3-hexanone\nOcfentanil N-(2-fluorophenyl)-2-methoxy-N-[1-(2-\nphenylethyl)piperidin-4yl]acetamide\nOpium the coagulated juice of the opium poppy (plant species\nPapaver somniferum L.)\nOripavine 3-O-demethylthebaine\nOxycodone 14-hydroxydihydrocodeinone (derivate of morphine)\nOxymorphone 14-hydroxydihydromorphinone (derivate of morphine)\nPara-Fluorofentanyl 4’-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide\nPEPAP 1-phenethyl-4-phenyl-4-piperidinol acetate (ester)\nPethidine 1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl\nester\nPethidine Intermediate A 4-cyano-1-methyl-4-phenylpiperidine\nPethidine Intermediate B 4-phenylpiperidine-4-carboxylic acid ethyl ester\nPethidine Intermediate C 1-methyl-4-phenylpiperidine-4-carboxylic acid\nPhenadoxone 6-morpholino-4,4-diphenyl-3-heptanone\nPhenampromide N-(1-methyl-2-piperidinoethyl)propionanilide\nPhenazocine 2’-hydroxy-5,9-dimethyl-2-phenethyl-6,7-\nbenzomorphan\nPhenomorphan 3-hydroxy-N-phenethylmorphinan\nPhenoperidine 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-\ncarboxylic acid ethyl ester\nPiminodine 4-phenyl-1-(3-phenylaminopropyl)piperidine-4-\ncarboxylic acid ethyl ester\nPiritramide 1-(3-cyano-3,3-diphenylpropyl)-4-(1-\npiperidino)piperidine-4carboxylic acid amide\n38 No. 2 of 2023] Controlled Substances\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nProheptazine 1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane\nProperidine 1-methyl-4-phenylpiperidine-4-carboxylic acid\nisopropyl ester\nRacemethorphan ()-3-methoxy-N-methylmorphinan\nRacemoramide ()-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-\npyrrolidinyl)butyl]morpholine\nRacemorphan ()-3-hydroxy-N-methylmorphinan\nRemifentanil 1-(2-methoxycarbonylethyl)-4-\n(phenylpropionylamino)-piperidine-4carboxylic acid\nmethyl ester\nSufentanil N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-\npiperidyl]propionanilide\nTetrahydrofuranylfentanyl (THF-F) N-phenyl-N-[1-(2-phenylethyl)piperidin-4-\nyl]tetrahydrofuran-2carboxamide\nThebacon Acetyldihydrocodeinone (acetylated enol form of\nhydrocodone)\nThebaine (an alkaloid of opium; also found in Papaver\nbracteatum)\nThiofentanyl N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide\nTilidine ()-ethyl-trans-2-(dimethylamino)-1-phenyl-3-\ncyclohexene-1carboxylate\nTrimeperidine 1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine\nU-47700 3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-\nmethyl-benzamide\nPart B: Psychotropic Substances\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nBrolamfetamine (±)-4-bromo-2,5-dimethoxy-á-methylphenethylamine\nCathinone (–)-(S)-2-aminopropiophenone\nDET 3-[2-(diethylamino)ethyl]indole\nDMA (±)-2,5-dimethoxy-á-methylphenethylamine\nDMHP 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-\ntrimethyl-6H dibenzo[b,d]pyran-1-ol\nDMT 3-[2-(dimethylamino)ethyl]indole\nDOET (±)-4-ethyl-2,5-dimethoxy-á-methylphenethylamine\nEticyclidine N-ethyl-1-phenylcyclohexylamine\nEtryptamine 3-(2-aminobutyl)indole\n(+)-Lysergide 9,10-didehydro-N,N-diethyl-6-methylergoline-8ß-\ncarboxamide\nN-hydroxy MDA (±)-N[α-methyl-3,4-\n(methylenedioxy)phenethyl]hydroxylamine\nControlled Substances [No. 2 of 2023 39\nPart B: Psychotropic Substances\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nMDE, N-ethyl (±)-N-ethyl-α-methyl-3,4-\nMDA (methylenedioxy)phenethylamine\nMDMA (±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine\nMescaline 3,4,5-trimethoxyphenethylamine\nMethcathinone 2-(methylamino)-1-phenylpropan-1-one\n4-methylaminorex (±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline\nMMDA 5-methoxy-á-methyl-3,4-(methylenedioxy)\nphenethylamine\n4-MTA α-methyl-4-methylthiophenethylamine\n25B-NBOMe 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-\nmethoxybenzyl)ethanamine\n25C-NBOMe 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-\nmethoxybenzyl)ethanamine\n25I-NBOMe 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-\nmethoxybenzyl)ethanamine\nPsilocybine 3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen\nphosphate\nRolicyclidine 1-(1-phenylcyclohexyl)pyrrolidine\n2,5-dimethoxy-á,4-dimethylphenethylamine\nTenamfetamine α-methyl-3,4-(methylenedioxy)phenethylamine\nTenocyclidine 1-[1-(2-thienyl)cyclohexyl]piperidine\nTetrahydrocannabinol tetrahydrocannabinol, the following isomers and their\nstereochemical variants:\ndelta-6a(10a)-THC 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-\ndibenzo[b,d]pyran-1-ol\ndelta-6a(7)-THC (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-\npentyl-6H dibenzo[b,d]pyran-1-ol\ndelta-7-THC (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-\n3-pentyl-6H dibenzo[b,d]pyran-1-ol\ndelta-8-THC (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-\npentyl-6H dibenzo[b,d]pyran-1-ol\ndelta-10-THC 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-\ndibenzo[b,d]pyran-1-ol\ndelta-9(11)-THC (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-\nmethylene3 pentyl-6H-dibenzo[b,d] pyran-1-ol\nTMA (±)-3,4,5-trimethoxy-á-methylphenethylamine\n40 No. 2 of 2023] Controlled Substances\nSECOND SCHEDULE\n(Sections 2,21,26 and 27)\nPart A: Narcotic Drugs\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nAcetyldihydrocodeine (derivative of codeine)\nCodeine 3-methylmorphine (derivate of morphine, alkaloid\ncontained in opium and poppy straw)\nDextropropoxyphene α-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-\n2butanol propionate (Dextro-rotary isomer of\npropoxyphene)\nDihydrocodeine (derivative of morphine)\nEthylmorphine 3-ethylmorphine (derivative of morphine)\nNicocodine 6-nicotinylcodeine (derivative of morphine)\nNicodicodine 6-nicotinyldihydrocodeine (derivative of morphine)\nNorcodeine N-demethylcodeine (derivative of morphine)\nPholcodine morpholinylethylmorphine (derivative of morphine)\nPropiram N-(1-methyl-2-piperidinoethyl)-N-\n2pyridylpropionamide\nPart B: Psychotropic Substances\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nAM-2201 [1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-\n1yl)methanone\nAmfetamine (±)-α-methylphenethylamine\nAmineptine 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5\nyl)amino]heptanoic acid\n5F-APINACA\nN-Benzylpiperazine 1-benzylpiperazine\n4-bromo-2,5-dimethoxyphenethylamine\nDexamfetamine (+)-á-methylphenethylamine\nDronabinola (6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-\n3-pentyl-6H-dibenzo[b,d]pyran-1-ol\nEthylone\nEthylphenidate\nFenetylline 7-[2-[(á- methylphenethyl)amino]ethyl]theophylline\nJWH-018 Naphthalene-1-yl(1-pentyl-1H-indol-3-yl) methanone\nLevamfetamine (–)-(R)-α-methylphenethylamine(amphetamine\n(-)isomer\nMDMB-CHMICA\nControlled Substances [No. 2 of 2023 41\nInternational non-proprietary\nname or other non-proprietary\nname or trivial names Chemical name\nMDPV (R/S)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-\n1-yl)pentan-1-one\nMecloqualone 3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone\nMephedrone (RS)-2-methylamino-1-(4-methylphenyl)propan-\n1-one\nMetamfetamine (+)-(S)-N,á-dimethylphenethylamine\nMetamfetamine Racemate (±)-N,á-dimethylphenethylamine\nMethaqualone 2-methyl-3-o-tolyl-4(3H)-quinazolinone\nMethiopropamine\nMethoxetamine 2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone\n4-Methylethcathinone (RS)-2-methylamino-1-(4-methylphenyl)propan-1-one\nMethylone (RS)- 2-methylamino-1-\n(3,4-methylenedioxyphenyl)propan-1-one\nMethylphenidate methyl á-phenyl-2-piperidine acetate\nPentedrone\nPhencyclidine 1-(1-phenylcyclohexyl)piperidine\nPhenmetrazine 3-methyl-2-phenylmorpholine\nSecobarbital 5-allyl-5-(1-methylbutyl)barbituric acid\nXLR-11\nZIPEPROL α-(α-methoxybenzyl)-4-(ß-methoxyphenethyl)-1-\npiperazineethanol\n42 No. 2 of 2023] Controlled Substances\nTHIRD SHEDULE\n(Sections 2,21 and 27)\nPart A: Preparations Containing Narcotic Drugs\nPreparations Containing Narcotic Drugs Contents\nAcetyldihydrocodeine, Codeine, when compounded with one or more other\nDihydrocodeine, Ethylmorphine, ingredients and containing not more than 100\nNicocodine, Nicodicodine, Norcodeine, milligrams of the drug per dosage unit and with\nPholcodine a concentration of not more than 2.5 per cent in\nundivided preparations.\nPropiram containing not more than 100 milligrams of\nPROPIRAM per dosage unit and compounded\nwith at least the same amount of\nmethylcellulose.\nDextropropoxyphene for oral use containing not more than 135\nmilligrams of DEXTROPROPOXYPHENE\nbase per dosage unit or with a concentration of\nnot more than 2.5 per cent in undivided\npreparations, provided that such preparations\ndo not contain any substance controlled under\nthe 1971 Convention on Psychotropic\nSubstances.\nCocaine containing not more than 0.1 per cent of cocaine\ncalculated as COCAINE base;\nOpium or Morphine containing not more than 0.2 per cent of\nMORPHINE calculated as anhydrous\nMORPHINE base and compounded with one\nor more other ingredients and in such a way\nthat the drug cannot be recovered by readily\napplicable means or in a yield which would\nconstitute a risk to public health.\nDifenoxin containing, per dosage unit, not more than 0.5\nmilligrams of DIFENOXIN and a quantity of\natropine sulfate equivalent to at least 5 per\ncent of the dose of DIFENOXIN.\nDiphenoxylate containing, per dosage unit, not more than 2.5\nmilligrams of DIPHENOXYLATE calculated\nas base and a quantity of atropine sulfate\nequivalent to at least 1 per cent of the dose of\nDIPHENOXYLATE.\nPulvis ipecacuanhae et opii compositus 10 per cent OPIUM in powder; 10 per cent\nipecacuanha root, in powder, well mixed with\n80 per cent of any other powdered ingredient\ncontaining no drug.\nPreparations conforming to any of the formulas listed in this Schedule and mixtures of such\npreparations with any material which contains no drug.\nPreparations containing ephedrine, pseudoephedrine and norephedrine, as follows:\nControlled Substances [No. 2 of 2023 43\nPart B: Psychotropic Substances\nInternational non-proprietary name\nor other non-proprietary name or\ntrivial names Chemical name\nAmobarbital 5-ethyl-5-isopentylbarbituric acid\nBuprenorphine 2l-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-\ntrimethylpropyl]-6,14 endo-ethano-6,7,8,14-\ntetrahydrooripavine\nButalbital 5-allyl-5-isobutylbarbituric acid\nCathine (+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol\nCyclobarbital 5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid\nEtizolam\nFlualprazolam\nFlunitrazepam 5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-\n2H-1,4 benzodiazepin-2-one\nGlutethimide 2-ethyl-2-phenylglutarimide\nPentazocine (2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-\ndimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-\nbenzazocin-8-ol\nPentobarbital 5-ethyl-5-(1-methylbutyl)barbituric acid\n44 No. 2 of 2023] Controlled Substances\nFOURTH SCHEDULE\n(Sections 2, 21 and 27)\nPart A: Narcotic Drugs\nInternational non-proprietary name\nor other non-proprietary name or\ntrivial names Chemical name\nAcetorphine 3-O-acetyltetrahydro-7α-(1-hydroxy-1-\nmethylbutyl)-6,14-endo-ethenooripavine\n(derivative of thebaine)\nAcetyl-Alpha-Methylfentanyl N-[1-(α-methylphenethyl)-4-\npiperidyl]acetanilide\nAcetylfentanyl N-Phenyl-N-[1-(2-phenylethyl)-\n4piperidinyl]acetamide\nAlpha-Methylfentanyl N-[1-(α-methylphenethyl)-4-\npiperidyl]propionanilide\nAlpha-Methylthiofentanyl N-[1-[1-methyl-2-(2-thienyl)ethyl]-\n4piperidyl]propionanilide\nBeta-Hydroxyfentanyl N-[1-(ß-hydroxyphenethyl)-4-\npiperidyl]propionanilide\nBeta-Hydroxy-3-Methylfentanyl N-[1-(ß-hydroxyphenethyl)-3-methyl-\n4piperidyl]propionanilide\nCannabis (Plant)4 _\nCannabis Resin5 _\nCarfentanil Methyl 1-(2-phenylethyl)-4-\n[phenyl(propanoyl)amino]piperidine-4-\ncarboxylate\nDesomorphine dihydrodesoxymorphine (derivative of\nmorphine)\nEtorphine tetrahydro-7á-(1-hydroxy-1-methylbutyl)-\n6,14-endoethenooripavine (derivative of\nthebaine)\nHeroin Diacetylmorphine (derivative of morphine)\nKetobemidone 4-m-hydroxyphenyl-1-methyl-4-\npropionylpiperidine\n3-Methylfentanyl N-(3-methyl-1-phenethyl-4-\npiperidyl)propionanilide\n3-Methylthiofentanyl N-[3-methyl-1-[2-(2-thienyl)ethyl]-\n4piperidyl]propionanilide\nMppp 1-methyl-4-phenyl-4-piperidinol\npropionate (ester)\nPara-Fluorofentanyl 4’-fluoro-N-(1-phenethyl-4-\npiperidyl)propionanilide\nPepap 1-phenethyl-4-phenyl-4-piperidinol acetate\n(ester)\nThiofentanyl N-[1-[2-(thienyl)ethyl]-4-\npiperidyl]propionanilide\n4 the flowering or fruiting tops of the cannabis plant (resin not extracted)\n5 the separated resin, crude or purified, obtained from the cannabis plant\nControlled Substances [No. 2 of 2023 45\nPart B: Psychotropic Substances\nInternational non-proprietary name\nor other non-proprietary name or\ntrivial names Chemical name\nAllobarbital 5,5-diallylbarbituric acid\nAlprazolam 8-chloro-1-methyl-6-phenyl-4H-s-\ntriazolo[4,3 α][1,4]benzodiazepine\nAmfepramone 2-(diethylamino)propiophenone\nAminorex 2-amino-5-phenyl-2-oxazoline\nBarbital 5,5-diethylbarbituric acid\nBenzfetamine N-benzyl-N,a-dimethylphenethylamine\nBromazepam 7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-\nbenzodiazepin- 2-one\nBrotizolam 2-bromo-4-(o-chlorophenyl)-9-methyl-6H-\nthieno[3,2-f]-s triazolo[4,3-\na][1,4]diazepine\nButobarbital 5-butyl-5-ethylbarbituricacid\nCamazepam 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-\n5-phenyl-2H-1,4 benzodiazepin-2-one\ndimethylcarbamate (ester)\nChlordiazepoxide 7-chloro-2-(methylamino)-5-phenyl-3H-1,4\nbenzodiazepine-4-oxide\nClobazam 7-chloro-1-methyl-5-phenyl-1H-1,5-\nbenzodiazepine-2,4(3H,5H)-dione\nClonazepam 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-\n1,4 benzodiazepin-2-one\nClorazepate 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-\n1,4 benzodiazepine-3-carboxylic acid\nClotiazepam 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-\nmethyl-2H thieno[2,3-e]-1,4-\ndiazepin-2-one\nCloxazolam 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-\ntetrahydro oxazolo-[3,2-\nd][1,4]benzodiazepin-6(5H)-one\nDelorazepam 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-\n2H-1,4 benzodiazepin-2-one\nDiazepam 7-chloro-1,3-dihydro-1-methyl-5-phenyl-\n2H-1,4 benzodiazepin-2-one\nEstazolam 8-chloro-6-phenyl-4H-s-triazolo[4,3-\nα][1,4]benzodiazepine\nEthchlorvynol 1-chloro-3-ethyl-1-penten-4-yn-3-ol\nEthinamate 1-ethynylcyclohexanolcarbamate\nEthyl Loflazepate ethyl 7-chloro-5-(o-fluorophenyl)-2,3-\ndihydro-2-oxo-1H 1,4- benzodiazepine-3-\ncarboxylate\nEtilamfetamine N-ethyl-α-methylphenethylamine\n46 No. 2 of 2023] Controlled Substances\nInternational non-proprietary name\nor other non-proprietary name or\ntrivial names Chemical name\nFencamfamin N-ethyl-3-phenyl-2-norbornanamine\nFenproporex (±)-3-[(α- 5\nmethylphenylethyl)amino]propionitrile\nFludiazepam 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-\nmethyl-2H-1,4 benzodiazepin-2-one\nFlurazepam 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-\nfluorophenyl)-1,3 dihydro-2H-\n10\n1,4-benzodiazepin-2-one\nHalazepam 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-\ntrifluoroethyl)-2H- 1,4- benzodiazepin-2-\none\nHaloxazolam 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-\n15\ntetrahydrooxazolo[3,2-d]\n[1,4]benzodiazepin-6(5H)-one\nKetazolam 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-\nphenyl-4H- [1,3]oxazino[3,2-\nd][1,4]benzodiazepin-4,7(6H)-dione\nLefetamine (–)-N,N-dimethyl-1,2-diphenylethylamine\nLoprazolam 6-(o-chlorophenyl)-2,4-dihydro-2-[(4-\nmethyl-1-piperazinyl) methylene]-8-\nnitro-1H-imidazo[1,2-\nα][1,4]benzodiazepin-1-one\nLorazepam 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-\nhydroxy-2H-1,4 benzodiazepin-2-one\nLormetazepam 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-\nhydroxy-1 methyl-2H-1,4-\nbenzodiazepin-2-one\nMazindol 5-(p-chlorophenyl)-2,5-dihydro-3H-\nimidazo[2,1-a]isoindol-5-ol\nMedazepam 7-chloro-2,3-dihydro-1-methyl-5-phenyl-\n1H-1,4 benzodiazepine\nMefenorex N-(3-chloropropyl)-α-\nmethylphenethylamine\nMeprobamate 2-methyl-2-propyl-1,3-\npropanedioldicarbamate\nMesocarb 3-(á-methylphenethyl)-N-\n(phenylcarbamoyl)sydnone imine\nMethylphenobarbital 5-ethyl-1-methyl-5-phenylbarbituric acid\nMethyprylon 3,3-diethyl-5-methyl-2,4-piperidine-dione\nMidazolam 8-chloro-6-(o-fluorophenyl)-1-methyl-4H-\nimidazo[1,5 α][1,4]benzodiazepine\nNimetazepam 1,3-dihydro-1-methyl-7-nitro-5-phenyl-\n2H-1,4 benzodiazepin-2-one\nControlled Substances [No. 2 of 2023 47\nInternational non-proprietary name\nor other non-proprietary name or\ntrivial names Chemical name\nNitrazepam 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-\nbenzodiazepin-2-one\nNordazepam 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-\nbenzodiazepin-2-one\nOxazepam 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-\n2H-1,4 benzodiazepin-2-one\nOxazolam 10-chloro-2,3,7,11b-tetrahydro-2-methyl-\n11b phenyloxazolo[3,2-\nd][1,4]benzodiazepin- 6(5H)-one\nPemoline 2-amino-5-phenyl-2-oxazolin-4-one\nPhenazepam 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-\n2H-1,4 benzodiazepin-2-one\nPhendimetrazine (+)-(2S,3S)-3,4-dimethyl-2-\nphenylmorpholine\nPhenobarbital 5-ethyl-5-phenylbarbituric acid\nPhentermine α,α-dimethylphenethylamine\nPinazepam 7-chloro-1,3-dihydro-5-phenyl-1-(2-\npropynyl)-2H-1,4 benzodiazepin-2-one\nPipradrol 1,1-diphenyl-1-(2-piperidyl)methanol\nPrazepam 7-chloro-1-(cyclopropylmethyl)-1,3-\ndihydro-5-phenyl-2H- 1,4-benzodiazepin-\n2-one\nPyrovalerone 4’-methyl-2-(1-pyrrolidinyl)valerophenone\nSecbutabarbital 5-sec-butyl-5-ethylbarbituric acid\nTemazepam 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-\n5-phenyl-2H-1,4 benzodiazepin-2-one\nTetrazepam 7-chloro-5-(1-cyclohexen-1-yl)-1,3-\ndihydro-1-methyl-2H- 1,4-\nbenzodiazepin-2-one\nTriazolam 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-\ns-triazolo[4,3 a][1,4] benzodiazepine\nVinylbital 5-(1-methylbutyl)-5-vinylbarbituric acid\nZolpidem N,N,6-trimethyl-2-p-tolylimidazo[1,2-\na]pyridine-3 acetamide\n48 No. 2 of 2023] Controlled Substances\nFIFTH SCHEDULE\n(Sections 2, 21, 23, 26, 27 and 38)\nPrecursor chemicals\nName Chemical names /descriptions\nN-Acetylanthranilic acid (benzoic acid, 2-(acetylamino)-)\n4-Anilino-N- (N-phenyl-1-(2-\nphenethylpiperidine phenylethyl)piperidin-4-amine)\nName Chemical names /descriptions\n(ANPP) 2\nEphedrine ([R-(R*,S*)]-α-[1-\n(methylamino)ethyl]-\nbenzenemethanol)\nErgometrine (ergoline-8-carboxamide,9,10-\ndidehydro-N-(2-\nhydroxy- 1-methylethyl)-6-methyl-\n[8ß(S)])\nErgotamine (ergotaman-3',6',18'-trione, 12'-\nhydroxy-2'-\nmethyl-5'- (phenylmethyl)-,(5α))\nIsosafrole (1,3-benzodioxole,5-(1-propenyl)-)\n((8ß)-9,10-didehydro-6-\nLysergic acid methylergoline-8-\ncarboxylic acid)\n3,4-Methylenedioxyphenyl-2- (2-propanone,1-\npropanone [3,4(methylenedioxy)phenyl]-)\n(R*,S*)-α-(1-\nNorephedrine aminoethyl)benzenemethanol\nN-Phenethyl-4-piperidone (1-(2-phenylethyl)-piperidin-4-one)\n(NPP)2\nPhenylacetic acid (benzeneacetic acid)\n1-Phenyl-2-propanone (1-phenyl-2-propanone)\nalpha-Phenylacetoacetonitrile\n(APAAN) (3-oxo-2-phenylbutanenitrile)\n(1,3-benzodioxole-5-\nPiperonal carboxaldehyde)\nPseudoephedrine ([S-(R*,R*)]-α-[1-\nbenzenemethanol) (methylamino)ethyl]-\nSafrole (1,3-benzodioxole,5-(2-propenyl)-)\nPiperidine Piperidine\nThe salts of the substances listed in this part whenever the existence of such salts is\npossible\nThis part may include preparations and substances that pose a potential threat to public health\nand includes anabolic steroids.\nControlled Substances [No. 2 of 2023 49\nSIXTH SCHEDULE\n(Section 2,5,26 and 38)\nName Chemical names\nAcetic anhydride (acetic oxide)\nPotassium permanganate (permanganic acid (HMnO4), potassium salt)\nEthyl ether (1,1’-oxybis[ethane])\nHydrochloric acid [1] (hydrochloric acid)\nMethyl ethyl ketone (2-butanone)\nSulphuric acid (sulfuric acid)\nToluene (benzene, methyl-)\nThe salts of the substances listed in this part whenever the existence of such salts is possible (the\nsalts of hydrochloric acid and sulphuric acid are specifically excluded)\n50",
  "source": "https://zambialii.org/akn/zm/act/2023/2/eng@2023-04-18",
  "type": "act",
  "related_files": [
    {
      "type": "pdf",
      "url": "https://zambialii.org/akn/zm/act/2023/2/eng@2023-04-18/source.pdf",
      "path": "lawdata\\zm_act_2023_2_eng@2023-04-18\\zm_act_2023_2_eng_2023-04-18.pdf"
    }
  ],
  "citations": []
}